SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-19-006100
Filing Date
2019-11-06
Accepted
2019-11-06 07:34:03
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 a2239984zs-3.htm S-3 433983
2 EX-1.2 a2239984zex-1_2.htm EX-1.2 251061
3 EX-4.5 a2239984zex-4_5.htm EX-4.5 461697
4 EX-4.6 a2239984zex-4_6.htm EX-4.6 498907
5 EX-4.7 a2239984zex-4_7.htm EX-4.7 57672
6 EX-4.8 a2239984zex-4_8.htm EX-4.8 57600
7 EX-5.1 a2239984zex-5_1.htm EX-5.1 49687
8 EX-23.1 a2239984zex-23_1.htm EX-23.1 3972
9 G739774.JPG g739774.jpg GRAPHIC 28454
10 G216442LAI001.GIF g216442lai001.gif GRAPHIC 1892
11 G216442LAI002.GIF g216442lai002.gif GRAPHIC 5316
  Complete submission text file 0001047469-19-006100.txt   1865113
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-234527 | Film No.: 191195084
SIC: 2836 Biological Products, (No Diagnostic Substances)